Detalhe da pesquisa
1.
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
J Neuroinflammation
; 18(1): 105, 2021 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33933106
2.
Pain, depression, and quality of life in adults with MOG-antibody-associated disease.
Eur J Neurol
; 28(5): 1645-1658, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33423336
3.
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
J Neuroinflammation
; 17(1): 261, 2020 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32883348
4.
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.
J Neuroinflammation
; 17(1): 262, 2020 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32883358
5.
Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.
J Neurol Neurosurg Psychiatry
; 2020 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219036
6.
Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders.
Eur Radiol
; 30(9): 5048-5058, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32335748
7.
Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders.
J Neurol Neurosurg Psychiatry
; 90(10): 1156-1164, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31127016
8.
Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort.
EClinicalMedicine
; 63: 102146, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37662515
9.
Alterations of NK Cell Phenotype During Pregnancy in Multiple Sclerosis.
Front Immunol
; 13: 907994, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35860238
10.
Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease: CHANCENMO Study.
Neurology
; 98(11): e1184-e1196, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35082170
11.
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders.
Neurol Neuroimmunol Neuroinflamm
; 9(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34785575
12.
Anti-aquaporin 4 IgG Is Not Associated With Any Clinical Disease Characteristics in Neuromyelitis Optica Spectrum Disorder.
Front Neurol
; 12: 635419, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33776892
13.
C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD.
J Neuroimmunol
; 360: 577699, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464830
14.
Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells.
Neurotherapeutics
; 18(3): 1783-1797, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34244929
15.
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders.
Mult Scler J Exp Transl Clin
; 7(2): 20552173211006862, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34017610
16.
Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study.
Neuroimage Clin
; 30: 102608, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33735786
17.
Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence.
Mult Scler Relat Disord
; 53: 103080, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171683
18.
Cortical topological network changes following optic neuritis.
Neurol Neuroimmunol Neuroinflamm
; 7(3)2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32123044
19.
Differences in Advanced Magnetic Resonance Imaging in MOG-IgG and AQP4-IgG Seropositive Neuromyelitis Optica Spectrum Disorders: A Comparative Study.
Front Neurol
; 11: 499910, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33101166
20.
Evaluation of the 'ring sign' and the 'core sign' as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis.
Mult Scler J Exp Transl Clin
; 6(1): 2055217320915480, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32284875